EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Echocardiographic Evaluation of Hypertrophic Cardiomyopathy

Karim Ali iD, Ahmed E Ali iD, Mohamed K Awad iD, Kyle Wansing iD, Mohamad Elgozair iD, Mohamed Abdalla iD, Cooper Gearhart iD, Ahmed Sami Abuzaid

Reviews in Cardiovascular Medicine · 12.10.2026 · 27 (10)

DOI: 10.31083/rcm51298 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 12.10.2026. Verfasst von Karim Ali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic and phenotypic myocardial disease where diagnosis and risk stratification extend beyond the mere detection of left ventricular hypertrophy. While echocardiography is the first-line imaging modality, this approach often offers limited insights into disease etiology, biological activity, and natural history. Thus, several non-echocardiographic modalities have emerged as prominent components of contemporary HCM investigations. Electrocardiography (ECG) provides early, readily accessible insights into myocardial remodeling and arrhythmic risk. Cardiac magnetic resonance (CMR) imaging enhances phenotyping through detailed tissue characterization and fibrosis assessment, while nuclear imaging uniquely evaluates myocardial perfusion and microvascular injury. Plasma biomarkers and genetic testing offer valuable insights into disease activity and risk stratification for affected individuals and at-risk relatives, especially when combined with imaging findings. Therefore, this review summarizes current knowledge on non-echocardiographic approaches to HCM, highlighting the associated complementary strengths and the value of integrated multimodality assessment in improving disease phenotyping, prognostication, and management. Importantly, integrating these modalities improves risk stratification for sudden cardiac death, heart failure progression, and arrhythmias, guiding decisions on implantable cardioverter-defibrillator (ICD) placement and medical management. This approach supports more personalized, mechanism-based care in HCM.

Schlagwörter

Stichwörter der Autor:innen

cardiacdiagnostic imagingelectrocardiographyhypertrophic cardiomyopathymagnetic resonance imagingmyocardial fibrosisphenotyperadionuclide imagingrisk assessment

Autor:innen und Institutionen

  • Department of Internal Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA.
  • Department of Internal Medicine, Crestwood Medical Center, Huntsville, AL 35801, USA.
  • Department of Critical Care, Faculty of Medicine, Ain Shams University, 1181 Cairo, Egypt.
  • Department of Internal Medicine, Zucker School of Medicine at Hofstra/Northwell, Danbury, CT 06810, USA.
  • Neuroscience Department, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Alaska Heart and Vascular Institute, University of Alaska, Anchorage, AK 99571, USA.

ORCID-Profile: Karim Ali, Ahmed E Ali, Mohamed K Awad, Kyle Wansing, Mohamad Elgozair, Mohamed Abdalla, Cooper Gearhart

Zitieren

APA

Ali, K., Ali, A. E., Awad, M. K., Wansing, K., Elgozair, M., Abdalla, M., Gearhart, C., & Abuzaid, A. S. (2026). Non-Echocardiographic Evaluation of Hypertrophic Cardiomyopathy. Reviews in Cardiovascular Medicine, 27(10). https://doi.org/10.31083/rcm51298

Vancouver

Ali K, Ali AE, Awad MK, Wansing K, Elgozair M, Abdalla M, et al. Non-Echocardiographic Evaluation of Hypertrophic Cardiomyopathy. Reviews in Cardiovascular Medicine. 2026;27(10). doi:10.31083/rcm51298

BibTeX
@article{Ali2026,
  author = {Ali, Karim and Ali, Ahmed E and Awad, Mohamed K and Wansing, Kyle and Elgozair, Mohamad and Abdalla, Mohamed and Gearhart, Cooper and Abuzaid, Ahmed Sami},
  title = {Non-Echocardiographic Evaluation of Hypertrophic Cardiomyopathy},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {10},
  doi = {10.31083/rcm51298}
}
Kostenlos starten →